Cost Effectiveness as a Criterion for Medicare Coverage
New England Journal of Medicine. 1989 Sep 28; 321(13): 898-900.
In a Sounding Board article, a physician comments upon and solicits support for the proposed rules for Medicare coverage issued by the federal Health Care Financing Administration in January 1989. The regulations propose that cost-effectiveness be included as a criterion for Medicare coverage of a technology or procedure. Leaf points out that many medical procedures in common usage never have been subjected to rigorous clinical testing to demonstrate their medical- or cost-effectiveness. He urges the development of simpler, less expensive methods than the randomized, double-blind, placebo-controlled clinical trial to evaluate efficacy. Leaf also calls for a clearer definition of the goals of the American health care system, whether the objective is increasing life expectancy or helping people remain in good health for as long as their biological life span permits. (KIE abstract)
Biomedical Technologies; Costs and Benefits; Economics; Evaluation; Federal Government; Financial Support; Goals; Government; Government Regulation; Health; Health Care; Health Care Delivery; Human Experimentation; Insurance; Life; Methods; Patient Care; Physicians; Public Policy; Quality of Life; Regulation; Resource Allocation; Technology;
Showing items related by title, author, creator and subject.
Leaf, Alexander (1989-09-28)
Grosse, Scott D. (2009)
Cost-Effectiveness as a Criterion for Public Spending on Health: A Reply to William Jack's "Second Opinion" Musgrove, Philip (2000-12)